The Predictive Value of p53, p27Kip1, and α-Catenin for Progression in Superficial Bladder Carcinoma

TNM Classification of Malignant Tumors

Darryl Carter · The American Journal of Surgical Pathology · 1998 · 6.4K citations

Tumor Heterogeneity, Medicine, Pathology +2

Cancer statistics, 2000

Robert T. Greenlee, Thomas S. Murray, S. Bolden et al. · CA A Cancer Journal for Clinicians · 2000 · 3.9K citations · Full text

American Cancer Society, Cancer Statistics, Cancer Epidemiology +14

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 2.9K citations

Individual Patients, Urology, Urologic Cancer Epidemiology +7

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

Kornélia Polyák, Mong-Hong Lee, Hediye Erdjument‐Bromage et al. · Cell · 1994 · 2.1K citations

Signal Transduction, Potential Mediator, Signaling Pathway +12

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

Cathy A. Finlay, Philip W. Hinds, Tse‐Hua Tan et al. · Molecular and Cellular Biology · 1988 · 1.1K citations · Full text

Gene Product, Hsc70-p53 Complex, Amino Acids +16